These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 26844592)

  • 21. Custom cerium oxide nanoparticles protect against a free radical mediated autoimmune degenerative disease in the brain.
    Heckman KL; DeCoteau W; Estevez A; Reed KJ; Costanzo W; Sanford D; Leiter JC; Clauss J; Knapp K; Gomez C; Mullen P; Rathbun E; Prime K; Marini J; Patchefsky J; Patchefsky AS; Hailstone RK; Erlichman JS
    ACS Nano; 2013 Dec; 7(12):10582-96. PubMed ID: 24266731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.
    Dumont M; Lin MT; Beal MF
    J Alzheimers Dis; 2010; 20 Suppl 2(Suppl 2):S633-43. PubMed ID: 20421689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of multifunctional antioxidants on mitochondrial dysfunction and amyloid-β metal dyshomeostasis.
    Kawada H; Blessing K; Kiyota T; Woolman T; Winchester L; Kador PF
    J Alzheimers Dis; 2015; 44(1):297-307. PubMed ID: 25227315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer's disease.
    Choi DY; Lee YJ; Hong JT; Lee HJ
    Brain Res Bull; 2012 Feb; 87(2-3):144-53. PubMed ID: 22155297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ceria-containing uncoated and coated hydroxyapatite-based galantamine nanocomposites for formidable treatment of Alzheimer's disease in ovariectomized albino-rat model.
    Wahba SM; Darwish AS; Kamal SM
    Mater Sci Eng C Mater Biol Appl; 2016 Aug; 65():151-63. PubMed ID: 27157738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondria as a therapeutic target in Alzheimer's disease and diabetes.
    Moreira PI; Cardoso SM; Pereira CM; Santos MS; Oliveira CR
    CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):492-511. PubMed ID: 19702564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondria as a pharmacological target: magnum overview.
    Olszewska A; Szewczyk A
    IUBMB Life; 2013 Mar; 65(3):273-81. PubMed ID: 23441041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerium oxide nanoparticles protect against Aβ-induced mitochondrial fragmentation and neuronal cell death.
    Dowding JM; Song W; Bossy K; Karakoti A; Kumar A; Kim A; Bossy B; Seal S; Ellisman MH; Perkins G; Self WT; Bossy-Wetzel E
    Cell Death Differ; 2014 Oct; 21(10):1622-32. PubMed ID: 24902900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caffeine increases mitochondrial function and blocks melatonin signaling to mitochondria in Alzheimer's mice and cells.
    Dragicevic N; Delic V; Cao C; Copes N; Lin X; Mamcarz M; Wang L; Arendash GW; Bradshaw PC
    Neuropharmacology; 2012 Dec; 63(8):1368-79. PubMed ID: 22959965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential of cerium oxide nanoparticles (nanoceria) for neurodegenerative disease therapy.
    Estevez AY; Erlichman JS
    Nanomedicine (Lond); 2014 Jul; 9(10):1437-40. PubMed ID: 25253491
    [No Abstract]   [Full Text] [Related]  

  • 32. In vivo administration of D609 leads to protection of subsequently isolated gerbil brain mitochondria subjected to in vitro oxidative stress induced by amyloid beta-peptide and other oxidative stressors: relevance to Alzheimer's disease and other oxidative stress-related neurodegenerative disorders.
    Ansari MA; Joshi G; Huang Q; Opii WO; Abdul HM; Sultana R; Butterfield DA
    Free Radic Biol Med; 2006 Dec; 41(11):1694-703. PubMed ID: 17145558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ceria nanoparticles: biomedical applications and toxicity.
    Fu X; Li P; Chen X; Ma Y; Wang R; Ji W; Gu J; Sheng B; Wang Y; Zhang Z
    J Zhejiang Univ Sci B; 2024 May; 25(5):361-388. PubMed ID: 38725338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondria: a therapeutic target in neurodegeneration.
    Moreira PI; Zhu X; Wang X; Lee HG; Nunomura A; Petersen RB; Perry G; Smith MA
    Biochim Biophys Acta; 2010 Jan; 1802(1):212-20. PubMed ID: 19853657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antioxidant modulation in restoring mitochondrial function in neurodegeneration.
    Pahrudin Arrozi A; Wan Ngah WZ; Mohd Yusof YA; Ahmad Damanhuri MH; Makpol S
    Int J Neurosci; 2017 Mar; 127(3):218-235. PubMed ID: 27074540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antioxidant therapies for Alzheimer's disease.
    Feng Y; Wang X
    Oxid Med Cell Longev; 2012; 2012():472932. PubMed ID: 22888398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary zeolite supplementation reduces oxidative damage and plaque generation in the brain of an Alzheimer's disease mouse model.
    Montinaro M; Uberti D; Maccarinelli G; Bonini SA; Ferrari-Toninelli G; Memo M
    Life Sci; 2013 May; 92(17-19):903-10. PubMed ID: 23562853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer's disease mice.
    Gao C; Wang Y; Sun J; Han Y; Gong W; Li Y; Feng Y; Wang H; Yang M; Li Z; Yang Y; Gao C
    Acta Biomater; 2020 May; 108():285-299. PubMed ID: 32251785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerium oxide nanoparticles: a 'radical' approach to neurodegenerative disease treatment.
    Naz S; Beach J; Heckert B; Tummala T; Pashchenko O; Banerjee T; Santra S
    Nanomedicine (Lond); 2017 Mar; 12(5):545-553. PubMed ID: 28181459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurotherapeutic effects of novel HO-1 inhibitors in vitro and in a transgenic mouse model of Alzheimer's disease.
    Gupta A; Lacoste B; Pistell PJ; Ingram DK; Hamel E; Alaoui-Jamali MA; Szarek WA; Vlahakis JZ; Jie S; Song W; Schipper HM
    J Neurochem; 2014 Dec; 131(6):778-90. PubMed ID: 25111043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.